LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Comprehensive Overview of Homogeneous Gold-Catalyzed Transformations of π-Systems for Application Scientists

    Ioannis Stylianakis / Antonios Kolocouris

    Catalysts, Vol 13, Iss 921, p

    2023  Volume 921

    Abstract: We present an overview of fundamental catalytic reactions of nucleophiles with π-systems in relation to gold chemistry. We present examples of reactions with gold-activated π-systems, alkynyl or allenyl moieties, and the regulation of their reactivity ... ...

    Abstract We present an overview of fundamental catalytic reactions of nucleophiles with π-systems in relation to gold chemistry. We present examples of reactions with gold-activated π-systems, alkynyl or allenyl moieties, and the regulation of their reactivity due to the presence of an electron-donating or -withdrawing group. The reactions describe furnished hard-to-reach heterocyclic building blocks for medicinal chemistry purposes. Important gold(I) or gold(III) complexes that are used as catalysts are presented. We examine the activation of such π-systems using gold(I) or gold(III) catalysts and the corresponding divergent catalytic transformations. We provide examples of divergent catalysis using gold(I) catalyst and other metal catalysts (Pt, Ag, Pd, Rh, Sc, Cu) or by changing the ligands in gold(I) catalyst complexes. We also discuss the role of the solvent, counterions and additives in gold(I)-catalyzed reactions. We mention, in a few cases, characteristic experimental or computational studies of these gold-catalyzed reactions of nucleophiles with π-systems.
    Keywords additives ; alkynyl substates ; allenyl substates ; counterions ; divergent catalysis ; homogeneous gold catalysis ; Chemical technology ; TP1-1185 ; Chemistry ; QD1-999
    Subject code 540
    Language English
    Publishing date 2023-05-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Improved Synthesis of the Antitubercular Agent SQ109

    Marianna Stampolaki / Antonios Kolocouris

    SynOpen, Vol 05, Iss 04, Pp 321-

    2021  Volume 326

    Abstract: We present here an improved procedure for the preparation of the promising antitubercular drug SQ109 that is currently in phase Ib/III of clinical trials against Mycobacterium tuberculosis. We investigated and tested the literature synthetic procedure ... ...

    Abstract We present here an improved procedure for the preparation of the promising antitubercular drug SQ109 that is currently in phase Ib/III of clinical trials against Mycobacterium tuberculosis. We investigated and tested the literature synthetic procedure that enables the development of structure–activity relationships and report the observed inconsistencies as well as presenting improvements or novelties for the more efficient preparation of SQ109. Most significantly we applied a novel reduction step of the aminoamide precursor using Me3SiCl­/LiAlH4 under mild conditions. These findings are important for research groups investigating the efficacy of this drug and analogues in academia and industry.
    Keywords sq109 ; tuberculosis ; synthesis ; reduction ; trimethylsilyl chloride ; geranylamine ; lithium aluminum hydride ; Chemistry ; QD1-999
    Language English
    Publishing date 2021-12-01T00:00:00Z
    Publisher Georg Thieme Verlag KG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Amantadine variant – aryl conjugates that inhibit multiple M2 mutant – amantadine resistant influenza a viruses

    Christina Tzitzoglaki / Anja Hoffmann / Andreea L. Turcu / Patrick Schmerer / Chunlong Ma / George Laros / Christos Liolios / Brea José / Jun Wang / Santiago Vázquez / Michaela Schmidtke / Antonios Kolocouris

    European Journal of Medicinal Chemistry Reports, Vol 6, Iss , Pp 100083- (2022)

    2022  

    Abstract: Influenza A viruses can cause a serious future threat due to frequent mutations. Amantadine and rimantadine drugs inhibit influenza A M2 wild-type (WT; bearing in the protein M2 proton channel serine at position-31) viruses by binding and blocking M2 WT ... ...

    Abstract Influenza A viruses can cause a serious future threat due to frequent mutations. Amantadine and rimantadine drugs inhibit influenza A M2 wild-type (WT; bearing in the protein M2 proton channel serine at position-31) viruses by binding and blocking M2 WT channel-mediated proton current. The resistant to these drugs influenza A viruses bearing the S31N mutant in the M2 proton channel can be inhibited by amantadine – aryl conjugates, in which amantadine and an aryl group are linked through a methylene, which block M2 S31N channel-mediated proton current. However, the M2 amantadine/rimantadine resistant viruses bearing one of the four mutations L26F, V27A, A30T, G34E in residues that line the M2 channel pore pose an additional concern for public health.Here, we designed 33 compounds based on the structure of three previously published and potent amantadine-aryl conjugates against M2 S31N virus, by replacing amantadine with 16 amantadine variants. The compounds were tested against M2 WT and the five M2 amantadine resistant viruses aiming at identifying inhibitors against multiple M2 mutant – amantadine resistant viruses.We identified 16 compounds that inhibited in vitro two influenza A viruses with M2 WT or L26F channels. Additionally, compounds 21 or 32 or 33, which are conjugates of the rimantadine variant with CMe2 (instead of CHMe in rimantadine) or the diamantylamine or the 4-(1-adamantyl)benzenamine with the 2-hydroxy-4-methoxyphenyl aryl group, were in vitro inhibitors against three influenza A viruses with M2 WT or L26F or S31N, while compound 21 inhibited also in vitro the M2 G34E virus and compound 32 inhibited also in vitro the M2 A30T virus. Also, using electrophysiology, we showed that compound 21 was an efficient blocker of the M2 WT and M2 L26F channels, compound 32 blocked efficiently the M2 WT channel and compound 33 blocked the M2 WT, L26F and V27A channels. The drug metabolism and pharmacokinetics studies showed that these compounds need further optimization.
    Keywords Amantadine - aryl conjugate ; In vitro antiviral activity ; CPE ; Electrophysiology ; Influenza A M2 protein ; A30T ; Pharmacy and materia medica ; RS1-441 ; Other systems of medicine ; RZ201-999
    Subject code 572 ; 500
    Language English
    Publishing date 2022-12-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Author Correction

    Trine Lisberg Toft-Bertelsen / Mads Gravers Jeppesen / Eva Tzortzini / Kai Xue / Karin Giller / Stefan Becker / Amer Mujezinovic / Bo Hjorth Bentzen / Loren B. Andreas / Antonios Kolocouris / Thomas Nitschke Kledal / Mette Marie Rosenkilde

    Communications Biology, Vol 4, Iss 1, Pp 1-

    Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro

    2021  Volume 2

    Keywords Biology (General) ; QH301-705.5
    Language English
    Publishing date 2021-12-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2

    Trine Lisberg Toft-Bertelsen / Mads Gravers Jeppesen / Eva Tzortzini / Kai Xue / Karin Giller / Stefan Becker / Amer Mujezinovic / Bo Hjorth Bentzen / Loren B. Andreas / Antonios Kolocouris / Thomas Nitschke Kledal / Mette Marie Rosenkilde

    Communications Biology, Vol 4, Iss 1, Pp 1-

    2021  Volume 10

    Abstract: Toft-Bertelsen et al. describe repurposing of anti-influenza drug amantadine and its derivatives for the treatment of SARS-CoV-2. They show that Amantadine, Emodin and Xanthene show significant blockage of ionchannels formed by SARS-CoV-2 which are ... ...

    Abstract Toft-Bertelsen et al. describe repurposing of anti-influenza drug amantadine and its derivatives for the treatment of SARS-CoV-2. They show that Amantadine, Emodin and Xanthene show significant blockage of ionchannels formed by SARS-CoV-2 which are crucial for its assembly and pathophysiology.
    Keywords Biology (General) ; QH301-705.5
    Language English
    Publishing date 2021-12-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Discovery of SARS-CoV‑2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay

    Chunlong Ma / Michael Dominic Sacco / Zilei Xia / George Lambrinidis / Julia Alma Townsend / Yanmei Hu / Xiangzhi Meng / Tommy Szeto / Mandy Ba / Xiujun Zhang / Maura Gongora / Fushun Zhang / Michael Thomas Marty / Yan Xiang / Antonios Kolocouris / Yu Chen / Jun Wang

    ACS Central Science, Vol 7, Iss 7, Pp 1245-

    2021  Volume 1260

    Keywords Chemistry ; QD1-999
    Language English
    Publishing date 2021-06-01T00:00:00Z
    Publisher American Chemical Society
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: Comparative Perturbation Effects Exerted by the Influenza A M2 WT Protein Inhibitors Amantadine and the Spiro[pyrrolidine-2,2′-adamantane] Variant AK13 to Membrane Bilayers Studied Using Biophysical Experiments and Molecular Dynamics Simulations

    Konstantinidi, Athina / Antonios Kolocouris / Barbara Sartori / Costas Demetzos / Dimitrios Ntountaniotis / Dimitris Kolokouris / Gregor Mali / Heinz Amentisch / Maria Chountoulesi / Nikolaos Naziris / Sophia Kiriakidi / Thomas Mavromoustakos

    Journal of physical chemistry. 2018 Oct. 04, v. 122, no. 43

    2018  

    Abstract: Aminoadamantane drugs are lipophilic amines that block the membrane-embedded influenza A M2 WT (wild type) ion channel protein. The comparative effects of amantadine (Amt) and its synthetic spiro[pyrrolidine-2,2′-adamantane] (AK13) analogue in ... ...

    Abstract Aminoadamantane drugs are lipophilic amines that block the membrane-embedded influenza A M2 WT (wild type) ion channel protein. The comparative effects of amantadine (Amt) and its synthetic spiro[pyrrolidine-2,2′-adamantane] (AK13) analogue in dimyristoylphosphatidylcholine (DMPC) bilayers were studied using a combination of experimental biophysical methods, differential scanning calorimetry (DSC), X-ray diffraction, solid-state NMR (ssNMR) spectroscopy, and molecular dynamics (MD) simulations. All three experimental methods pointed out that the two analogues perturbed drastically the DMPC bilayers with AK13 to be more effective at high concentrations. AK13 was tolerated in lipid bilayers at very high concentrations, while Amt was crystallized. This is an important consideration in the formulations of drugs as it designates a limitation of Amt incorporation. MD simulations verify provided details about the strong interactions of the drugs in the interface region between phosphoglycerol backbone and lipophilic segments. The two drugs form hydrogen bonding with both water and sn-2 carbonyls in their amine form or water and phosphate oxygens in their ammonium form. Such localization of the drugs explains the DMPC bilayers reorientation and their strong perturbing effect evidenced by all biophysical methodologies applied.
    Keywords amines ; ammonium ; differential scanning calorimetry ; drugs ; hydrogen bonding ; influenza ; ion channels ; lipid bilayers ; lipophilicity ; molecular dynamics ; nuclear magnetic resonance spectroscopy ; phosphates ; simulation models ; X-ray diffraction
    Language English
    Dates of publication 2018-1004
    Size p. 9877-9895.
    Publishing place American Chemical Society
    Document type Article
    ISSN 1520-5207
    DOI 10.1021/acs.jpcb.8b07071
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top